Ratings The New York Times Company Deutsche Boerse AG

Equities

NYT

US6501111073

Market Closed - Deutsche Boerse AG 02:03:07 2024-07-16 am EDT 5-day change 1st Jan Change
49.05 EUR +1.15% Intraday chart for The New York Times Company +2.51% +12.06%

Summary

  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Analyst opinion has improved significantly over the past four months.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • With an enterprise value anticipated at 3.27 times the sales for the current fiscal year, the company turns out to be overvalued.
  • The company appears highly valued given the size of its balance sheet.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.

Ratings chart - Surperformance

Sector: Consumer Publishing

1st Jan change Capi. Investor Rating ESG Refinitiv
+12.06% 8.8B -
+15.85% 15.89B
B+
-7.86% 848M - -
+37.77% 816M -
+31.41% 596M -
D+
+33.51% 413M
B
+0.55% 266M - -
+127.80% 232M -
B-
-10.46% 153M
C
-18.11% 143M -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
-
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. NYT Stock
  4. NYT Stock
  5. Ratings The New York Times Company